SA
APOIX logo
American Century Short Duration Inflation Protection Bond Fund Investor Class(APOIX)
Last print 16 weeks agoAbout this dataData status
$10.44▲0.03 (0.29%)Stale · 16 weeks old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
APOIX logo

APOIX SBC to Revenue

Current (TTM)0.00%
APOIX SBC/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

What is sbc to revenue?

Stock-based compensation as percentage of revenue.

APOIX sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

American Century Short Duration Inflation Protection Bond Fund Investor Class SBC to Revenue — Annual fiscal periods
Period endingSBC to RevenueChange
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%—

Frequently asked questions: APOIX sbc to revenue

What is American Century Short Duration Inflation Protection Bond Fund Investor Class (APOIX)'s current sbc to revenue?

American Century Short Duration Inflation Protection Bond Fund Investor Class (APOIX)'s latest reported sbc to revenue (TTM) is 0.00% as of Nov 21, 2026. Stock-based compensation as percentage of revenue.

How much historical sbc to revenue data is available for APOIX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for American Century Short Duration Inflation Protection Bond Fund Investor Class (APOIX)'s sbc to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare APOIX's sbc to revenue to peers or set an alert?

You can open APOIX's sbc to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on APOIX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.